BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24436116)

  • 1. Fecal occult blood testing remains a valuable screening tool.
    Barton MK
    CA Cancer J Clin; 2014; 64(1):3-4. PubMed ID: 24436116
    [No Abstract]   [Full Text] [Related]  

  • 2. [Necessity and feasibility of screening for colorectal cancer in China].
    Zhang SZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):16-8. PubMed ID: 21271373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in performance of fecal occult blood testing.
    Brenner H; Haug U; Hundt S
    Am J Gastroenterol; 2010 Nov; 105(11):2457-64. PubMed ID: 20700114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2011 Oct; 34 Suppl 2():60-6. PubMed ID: 22330158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal occult blood testing.
    Sanford KW; McPherson RA
    Clin Lab Med; 2009 Sep; 29(3):523-41. PubMed ID: 19840685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.
    Park DI; Ryu S; Kim YH; Lee SH; Lee CK; Eun CS; Han DS
    Am J Gastroenterol; 2010 Sep; 105(9):2017-25. PubMed ID: 20502450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Oono Y; Iriguchi Y; Doi Y; Tomino Y; Kishi D; Oda J; Takayanagi S; Mizutani M; Fujisaki T; Yamamura A; Hosoi T; Taguchi H; Kosaka M; Delgado P
    Clin Chim Acta; 2010 Jun; 411(11-12):802-5. PubMed ID: 20184867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New fecal occult blood tests may improve adherence and mortality rates.
    Kumaravel V; Hayden SP; Hall GS; Burke CA
    Cleve Clin J Med; 2011 Aug; 78(8):515-20. PubMed ID: 21807923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening].
    García Sánchez J
    Rev Clin Esp; 2012 Jul; 212(7):407. PubMed ID: 22937539
    [No Abstract]   [Full Text] [Related]  

  • 10. To scope or to test for colorectal cancer screening?
    Sporea I; Popescu A
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):11-2. PubMed ID: 23539408
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for colorectal cancer in individuals at average risk: current methods and emerging issues.
    Lieberman D
    JAMA Intern Med; 2014 Jan; 174(1):10-1. PubMed ID: 24145734
    [No Abstract]   [Full Text] [Related]  

  • 12. Colorectal cancer screening in Europe: compliance and the choice of test.
    Riemann JF
    Endoscopy; 2010 Jul; 42(7):576-7. PubMed ID: 20593335
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening and surveillance for colorectal cancer: state of the art.
    Kahi CJ; Anderson JC; Rex DK
    Gastrointest Endosc; 2013 Mar; 77(3):335-50. PubMed ID: 23410695
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening could prevent more than half of colorectal cancer deaths. Virtual colonoscopy is gaining traction due to ease of procedure compared to standard colonoscopy.
    Duke Med Health News; 2012 May; 18(5):1-2. PubMed ID: 22649829
    [No Abstract]   [Full Text] [Related]  

  • 15. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for colorectal cancer: recommendations].
    Vonlaufen A; Troillet FX; Armenian B
    Rev Med Suisse; 2013 Apr; 9(381):754-7. PubMed ID: 23659152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
    Allameh Z; Davari M; Emami MH
    Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2012 Sep; 35 Suppl 1():68-73. PubMed ID: 23018010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.